Lifecore Biomedical
LFCR
93 hedge funds and large institutions have $335M invested in Lifecore Biomedical in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 29 reducing their positions, and 13 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
21% more capital invested
Capital invested by funds: $278M → $335M (+$57.4M)
3% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 29
4% less funds holding
Funds holding: 97 → 93 (-4)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$2.78M |
| 2 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$1.27M |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$764K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$600K |
| 5 |
Neuberger Berman Group
New York
|
+$510K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$5.21M |
| 2 |
GACM
Global Alpha Capital Management
Montreal,
Quebec, Canada
|
-$2.33M |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$1.84M |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$1.21M |
| 5 |
RA
Royce & Associates
New York
|
-$918K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
101
Paradigm Asset Management
New York
| – | -$17.2K | -1,600 | Closed |
|
102
Group One Trading
Chicago,
Illinois
| – | -$6K | -600 | Closed |
|
103
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$1K | -83 | Closed |
|
LFCR Hedge Fund Activity: Q3 2016 in Review
93 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q3 2016, worth a combined $335M — up 21% from $278M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of LFCR and 9 opened new positions — a net loss of 4 holders — while 29 trimmed existing stakes and 30 added.
The largest buyer was NWQ Investment Management Company, adding an estimated $2.78M. The largest seller was Ariel Investments, cutting an estimated $5.21M.
- 93 institutional investors held Lifecore Biomedical (LFCR) as of Q3 2016, down from 97 in Q2 2016.
- Funds reported $335M of Lifecore Biomedical stock for Q3 2016, up 21% quarter-over-quarter.
- 9 funds opened new Lifecore Biomedical positions in Q3 2016 and 13 closed out, a net change of -4 holders.
- The largest Lifecore Biomedical buyer in Q3 2016 was NWQ Investment Management Company, an estimated $2.78M added.
- The largest Lifecore Biomedical seller in Q3 2016 was Ariel Investments, an estimated $5.21M sold.
Based on aggregated 13F filings for Q3 2016.